Evidence map›Paper›PMID 34289370›Full record

ArticleCell reports2021

The histone chaperone HIR maintains chromatin states to control nitrogen assimilation and fungal virulence.

Sabrina Jenull, Theresia Mair, Michael Tscherner, Philipp Penninger, Florian Zwolanek, Fitz-Gerald S Silao, Kontxi Martinez de San Vicente, Michael Riedelberger, Naga C Bandari, Raju Shivarathri and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Proteome Remodelling inJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Journal of proteome research · 2025
    Article
  3. Echinocandin Adaptation inJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Sabrina JenullDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Theresia MairDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Michael TschernerDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Philipp PenningerDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Florian ZwolanekDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Fitz-Gerald S SilaoDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden.
Kontxi Martinez de San VicenteSection of Immunology, Vetsuisse Faculty, University of Zürich, 8006 Zürich, Switzerland; Institute of Experimental Immunology, University of Zürich, 8057 Zürich, Switzerland.
Michael RiedelbergerDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Naga C BandariARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Queensland 4072, Australia.
Raju ShivarathriPublic Health Research Institute, Rutgers, The State University of New Jersey, Newark, NJ 07102, USA.
Andriy PetryshynDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria.
Neeraj ChauhanPublic Health Research Institute, Rutgers, The State University of New Jersey, Newark, NJ 07102, USA; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, USA.
Lucia F ZacchiARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Queensland 4072, Australia.
Salomé LeibundGut -LandmannSection of Immunology, Vetsuisse Faculty, University of Zürich, 8006 Zürich, Switzerland; Institute of Experimental Immunology, University of Zürich, 8057 Zürich, Switzerland.
Per O LjungdahlDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden.
Karl KuchlerDepartment of Medical Biochemistry, Max Perutz Labs Vienna, Medical University of Vienna, Campus Vienna Biocenter, 1030 Vienna, Austria. Electronic address: karl.kuchler@meduniwien.ac.at.
Max Perutz Labs · ATVienna Biocenter · ATMedical University of Vienna · ATRutgers, The State University of New Jersey · USStockholm University · SEUniversity of Queensland · AUUniversity of Zurich · CH

Funding

The Candida albicans acetylome in fungal virulenceR01AI124499 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHAUHAN, NEERAJ · 2016 to 2019
$1.6M
Austrian Science Fund FWF P 32582NIAID NIH HHS R01 AI124499
6 · The paper itself

Abstract

Adaptation to changing environments and immune evasion is pivotal for fitness of pathogens. Yet, the underlying mechanisms remain largely unknown. Adaptation is governed by dynamic transcriptional re-programming, which is tightly connected to chromatin architecture. Here, we report a pivotal role for the HIR histone chaperone complex in modulating virulence of the human fungal pathogen Candida albicans. Genetic ablation of HIR function alters chromatin accessibility linked to aberrant transcriptional responses to protein as nitrogen source. This accelerates metabolic adaptation and increases the release of extracellular proteases, which enables scavenging of alternative nitrogen sources. Furthermore, HIR controls fungal virulence, as HIR1 deletion leads to differential recognition by immune cells and hypervirulence in a mouse model of systemic infection. This work provides mechanistic insights into chromatin-coupled regulatory mechanisms that fine-tune pathogen gene expression and virulence. Furthermore, the data point toward the requirement of refined screening approaches to exploit chromatin modifications as antifungal strategies.

Indexed as

Adaptation, PhysiologicalAnimalsCandida albicansCandidiasisChromatinFungal ProteinsGene DeletionGenetic LociHistone ChaperonesMacrophagesMiceMice, Inbred C57BLNitrogenProteolysisTranscription, GeneticVirulenceChromatinFungal ProteinsHistone ChaperonesNitrogenCandida albicansextracellular proteasesfungal pathogenhistone chaperonehypervirulenceimmune recognitionmetabolic genesnitrogen assimiliationsystemic infections

Identifiers

PMID34289370
PMCPMC8493472
OpenAlexW3184854645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.